Zacks Investment Research
18 Jun 2026, 17:51 UTC · 3h ago
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
18 Jun 2026, 17:51 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Penumbra, Inc. (PEN) received the CE Mark in Europe for its THUNDERBOLT computer-assisted vacuum thrombectomy technology. — Regulatory approval in a major market like Europe expands the addressable market and revenue potential for a core product.
+0.40Zacks Consensus Estimates for 2026 project a 32.3% year-over-year increase in earnings and 13.3% revenue growth for Penumbra. — Strong projected growth rates typically support a higher valuation and positive investor sentiment.
+0.30Penumbra's international revenues grew 16.5% year-over-year in Q1 2026, accounting for 20.9% of total revenues. — Demonstrates successful geographic diversification and scaling of commercial resources outside the US.
+0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
Company received CE Mark in Europe for its THUNDERBOLT technology, which is expected to boost market sentiment and diversify revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
8h ago
